Weight and behavior Management in a Patient with SmithMagenis Syndrome : Role of GLP-1 Receptor Agonists

Correia, Jorge; Pataky, Zoltan

doi:10.1159/000545547

Conference presentation

English

Weight and behavior Management in a Patient with SmithMagenis Syndrome : Role of GLP-1 Receptor Agonists

ContributorsCorreia, Jorge

; Pataky, Zoltan

Presented at32nd European Congress on Obesity (ECO 2025), Malaga, 11-14, May 2025

Presentation date2025-05-12

NotePublié dans : Obesity facts, 2025, 18 (suppl. 1) : 382

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires

Research groups

Pied diabétique (1043)

Citation (ISO format)

CORREIA, Jorge, PATAKY, Zoltan. Weight and behavior Management in a Patient with SmithMagenis Syndrome : Role of GLP-1 Receptor Agonists. In: 32nd European Congress on Obesity (ECO 2025). Malaga. 2025. doi: 10.1159/000545547

Presentation

CC BY-NC-4.0

Identifiers

PID : unige:185194
DOI : 10.1159/000545547
PMID : 40354783

Additional URL for this publicationhttps://karger.com/article/doi/10.1159/000545547

51views

73downloads

Creation26/05/2025 09:53:42

First validation27/05/2025 09:03:26

Update27/05/2025 09:03:26

Status update27/05/2025 09:03:26

Last indexation27/05/2025 09:03:27

Archive ouverte UNIGE

Weight and behavior Management in a Patient with SmithMagenis Syndrome : Role of GLP-1 Receptor Agonists

Technical informations